A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling

A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling

Fms-like tyrosine kinase-3 is a commonly mutated gene in acute myeloid leukemia, with about one-third of patients carrying an internal-tandem duplication of the juxtamembrane domain in the receptor (FLT3-ITD). FLT3-ITD exhibits altered signaling quality, including aberrant activation of STAT5. To id...

Full description

Bibliographic Details
Main Authors:	Caldarelli, A, Müller, J P, Paskowski-Rogacz, M, Herrmann, K, Bauer, R, Koch, S, Heninger, A K, Krastev, D, Ding, L, Kasper, S, Fischer, T, Brodhun, M, Böhmer, F-D, Buchholz, F
Format:	Online
Language:	English
Published:	Nature Publishing Group 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865536/

Similar Items

Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML
by: Wang, Aoli, et al.
Published: (2016)

Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
by: Kasper, S, et al.
Published: (2012)

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression
by: Arora, Deepika, et al.
Published: (2012)

FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia
by: Takenokuchi, Mariko, et al.
Published: (2012)

Overcoming AC220 resistance of FLT3-ITD by SAR302503
by: Kesarwani, M, et al.
Published: (2013)

Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia
by: Pillinger, Genevra, et al.
Published: (2015)

Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia
by: LI, CHENGLONG, et al.
Published: (2016)

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
by: Green, Alexa S., et al.
Published: (2015)

Prolonged cellular midostaurin retention suggests potential alternative dosing strategies for FLT3-ITD-positive leukemias
by: Lipka, D B, et al.
Published: (2016)

Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length
by: Kim, Y, et al.
Published: (2015)

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
by: Cummins, K D, et al.
Published: (2014)

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
by: Cummins, K D, et al.
Published: (2014)

From RNAi Screens to Molecular Function in Embryonic Stem Cells
by: Ding, Li, et al.
Published: (2011)

Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML
by: Stirewalt, D L, et al.
Published: (2014)

The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
by: How, J, et al.
Published: (2013)

Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia
by: Finnon, R, et al.
Published: (2012)

PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy
by: Zhou, Jianbiao, et al.
Published: (2011)

Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse
by: Park, Sang Hyuk, et al.
Published: (2011)

FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent Progenitors
by: Mead, Adam J., et al.
Published: (2013)

Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia
by: Rickmann, Mareike, et al.
Published: (2013)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
by: Park, Jung Eun, et al.
Published: (2013)

A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice
by: Mupo, A, et al.
Published: (2013)

FLT-3 ITD Positive Acute Basophilic Leukemia with Rare Complex Karyotype Presenting with Acute Respiratory Failure: Case Report
by: Antohe Ion, et al.
Published: (2018-01-01)

Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
by: Al-Mawali, Adhra, et al.
Published: (2016)

FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
by: Chougule, Rohit A., et al.
Published: (2016)

Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to Flt3-ITD mutations
by: Porter, Shaina N, et al.
Published: (2016)

Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia
by: Wobus, Manja, et al.
Published: (2015)

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
by: Bertoli, Sarah, et al.
Published: (2015)

Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
by: Cauchy, Pierre, et al.
Published: (2015)

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia
by: Qu, Shuang, et al.
Published: (2014)

Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation
by: Fouladi, Fariba, et al.
Published: (2015)

Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
by: Moore, Andrew S., et al.
Published: (2012)

Syk kinase and Shp2 phosphatase inhibition cooperate to reduce FLT3-ITD-induced STAT5 activation and proliferation of acute myeloid leukemia
by: Richine, Briana M., et al.
Published: (2016)

Association of the Protein-Tyrosine Phosphatase DEP-1 with Its Substrate FLT3 Visualized by In Situ Proximity Ligation Assay
by: Böhmer, Sylvia-Annette, et al.
Published: (2013)

The Protein Tyrosine Phosphatase, Shp2, Positively Contributes to FLT3-ITD-Induced Hematopoietic Progenitor Hyperproliferation and Malignant Disease In Vivo
by: Nabinger, Sarah C., et al.
Published: (2012)

Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients
by: Hong, Seung-Dok, et al.
Published: (2011)

Early Death in Two Patients with Acute Promyelocytic Leukemia Presenting the bcr3 Isoform, FLT3-ITD Mutation, and Elevated WT1 Level
by: Greco, Marianna, et al.
Published: (2013)

Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature
by: Senapati, Jayastu, et al.
Published: (2014)

Mutation Analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese Patients with Myeloproliferative Neoplasms
by: Wang, Min, et al.
Published: (2014)

Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations
by: Fei Li, et al.
Published: (2018-05-01)